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Abstract
Objective: Generalized Joint Hypermobility (GJH) is defined as a condition in which several joints move beyond
their normal limits. It seems to be associated with musculoskeletal disorders, pain, reduced activity level in sports
and reduced strength. The aim of the current study was to record specific problems and disorders of hypermobile
women and to build subgroups based on these results. As a second objective, the study aimed to identify
differences in activity level between these subgroups.
Methods: A total of 195 women were included in this exploratory study: 67 normomobile (NM) and 128
hypermobile. Of these, 56 were classified as hypermobile with symptoms and 47 as hypermobile without symptoms.
Symptoms were first recorded with the Canadian Occupational Performance Measure (COPM) and then monthly
over a period of 6 months with a face validated questionnaire including general impairment, localization, type,
intensity and frequency of problems. Activity level was determined by the International Physical Activity
Questionnaire.
Results: On the COPM there was no significant difference between patients in the NM and HM groups. The face
validated questionnaire identified the most important problem to be pain in different localizations after remaining in
one position for too long. The highest activity level was found in the HM group (p=0.021).
Conclusion: Hypermobile women are active for longer during the day than women with normal mobility, but the
type and degree of activity needs further evaluation. More detailed recording of symptoms in women with GJH is
required to identify the discrete differences between the groups. To build subgroups in GJH the procedure of
screening has to be more comprehensive. Widespread pain and level of activity are aspects that have to be included
in the holistic approach to the management of patients with GJH.
Keywords: Joint instability; Collagen diseases; Pain; Survey;
Questionnaires; Activities of daily living
Introduction
Musculoskeletal problems are common causes requiring primary
health care. Many people with everyday non-inflammatory
musculoskeletal problems may have an undiagnosed generalized joint
hypermobility (GJH). Some of them even have the more complex
multi-systemic condition called joint hypermobility syndrome (JHS).
Studies have shown that participants perceived a lack of awareness of
JHS in health professionals and more widely in society [1,2].
Joint mobility depends on age, sex and ethnical group and women
are usually more often affected by joint hypermobility. According to
Graham et al. [3], joint mobility commonly diminishes with age.
Mulvey et al. [4] found in a recent survey that the prevalence of joint
hypermobility in a general population in the UK was 18%. In this
study, joint hypermobility was linked to musculoskeletal disorders and
hypermobile participants had a 40% increased risk of reporting severe
chronic widespread pain. Furthermore, recurrent joint dislocation or
subluxation, arthralgia, soft tissue injuries, back and neck pain as well
as fibromyalgia, chronic fatigue syndrome and early osteoarthritis were
all associated with joint hypermobility [2,5]. Postural tachycardia
syndrome is also one common disorder, which may be associated with
joint hypermobility syndrome [6,7].
GJH is mainly diagnosed by the Beighton Score, which includes the
angular range of movement of selected joints [8]. The 5-point score of
Grahame and Hakim is a short questionnaire to detect generalized
joint hypermobility [9]. Another tool, the Brighton Criteria, contain
more information about the medical history like symptoms, problems
with skin, the appearance and constitution of the affected person and
lead to the diagnosis of JHS [10].
In 2016 the diagnostic criteria for JHS were revised [11]. Criteria
1-3 are mandatory and are composed as follows:
Criterion 1: Generalized Joint Hypermobility (GJH)
Criterion 2: Two or more of the following features (A–C) must be
present
• A: Systemic manifestations of a more generalized connective tissue
disorder
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• B: Positive family history with one or more first degree relatives
independently meeting the current diagnostic criteria for Ehlers-
Danlos-Syndrome
• C: Musculoskeletal complications (must have at least one) 
Criterion 3: All the following prerequisites must be met
• A: Absence of unusual skin fragility
• B: Exclusion of other heritable connective tissue disorders
• C: Exclusion of alternative diagnoses
Several authors examined neuromuscular abilities in hypermobile
patients classified as GJH and/or JHS compared to normomobile
persons. In one study, less precise proprioception was observed in
patients with JHS compared to normomobile subjects [12]. Persons
with JHS showed reduced balance capabilities compared to
normomobile persons. Changes in muscle reflex activity were
observed, which could be a possible explanation for the reduced
balance [13]. Another study showed that women with GJH without
symptoms have a higher rate of force development in the knee
extensors than normomobile women [14]. Also, some evidence was
found that muscle strength and functional performance of the lower
extremity is reduced in women with hypermobile Ehlers-Danlos
syndrome [15]. The same group found in a previous study that patients
with hypermobile Ehlers-Danlos syndrome demonstrated a significant
impairment in knee joint reposition sense and a lower level of sports
and physical activity than controls [16]. A systematic review and meta-
analysis showed that lower limb proprioception is reduced in people
with GJH [17]. In another study an exercise program improved balance
and strength and also reduced pain and an improvement in quality of
life was observed as a consequence [18]. Unfortunately, the details of
the home-based training protocol were unclear. In another study
hypermobile women compared to normomobile women showed
altered movement patterns during stair climbing aimed at avoiding
high muscle activation [19]. The result of a further study indicated that
hypermobile women compared to normomobile women might alter
their gait pattern in order to stabilize their knee joint [20]. In
summary, there is a lack of information to explain how symptoms and
neuromuscular abilities are linked to each other.
The overall physiotherapeutic management of persons with JHS is
focused on advice, education, exercise and self-management, but more
specific knowledge is still required [21,22]. There is some evidence
from another study that people with JHS improve with exercise but
there is no convincing evidence for specific types of exercise or that
exercise is better than control. Schmidt et al. [23] in their study
investigated how people with joint hypermobility syndrome make
decisions about activity. A few activities were avoided because of such
fears; others were undertaken when benefits outweighed costs in pain
and distress. They suggested that activity needs to be discussed with
patients beyond asking about avoidance and within the context of their
lifestyle choices.
In summary, current knowledge about diagnosis, treatment and
management of patients with joint hypermobility brings us to the aims
of the current study:
• To record specific problems and disorders of women with GJH
compared to women with normal mobility,
• To build subgroups within the group of GJH, namely hypermobile
women with and without symptoms,
• To identify differences in activity level between women with
normal mobility and hypermobile women with and without
symptoms.
Methodology
Study design
This project was a prospective exploratory cross-sectional study.
Here we present a secondary, exploratory analysis of the data
concerning pain, disability and daily life activity. All investigators who
completed the measurements were blinded to group allocation. The
main results of the project were published elsewhere [19,24-26]. The
study was approved by Canton Bern’s Ethics Committee (#229/2008)
and all participants gave written informed consent. Financial support
was given by the Swiss National Science Foundation (#13DPD6
127285).
Participants
The study participants were recruited ad hoc from the staff of the
University Hospital Berne and the student body of the Berne
University of Applied Sciences. Fact sheets with general information
about the study were distributed in the aforementioned institutions.
Additionally the study information was spread out via the local
physiotherapy association and among rheumatologists.
The first contact with interested persons was made by an
independent physiotherapist by telephone. On this occasion, inclusion
and exclusion criteria were checked and information was provided
concerning time and place where the measurements took place. At this
time several persons were rejected from participation, because the
inclusion criteria were not fulfilled or the persons declined
participation for personal reasons, lack of time or inconvenient
location of the measurements. When a person agreed to participate, an
appointment for the inclusion and the measurements was set.
Inclusion criteria were checked by the same independent
physiotherapist, which was not involved in the following
measurements. After inclusion, the questionnaires were filled out in a
separate room and the additional measurements performed. Finally,
the follow-up questionnaires for six months (see below) were handed
out with the relevant instructions.
The inclusion criteria were the following: women aged 18-40 years,
BMI ranging from 18-30 kg/m2, absence of a severe pain situation or
disability that would restrict the completion of all measurements.
Women for the hypermobile group (HM) were additionally defined by
the Beighton Score ≥ 6/9, those in the group with normal mobility
(NM) were allowed a maximum of 1/9 [9]. The cut-off was fixed at 6/9
and 0-1/9, respectively, to achieve a clear distinction between HM and
NM [24]. In addition, hypermobile participants had to fulfill
mandatory criteria such as hyperextension of the right and/or left knee
and/or forward flexion of the trunk with straight legs so that the palms
of the hands touch the floor completely. These movements were
required because additional biomechanical measurements on the right
leg were performed. Exclusion criteria for both groups were surgeries
or trauma of the lower leg or lumbar spine and pregnancy within the
past 2 years. In addition, women with a diagnosis of Marfan’s
Syndrome, Ehlers-Danlos syndrome I and II or osteogenesis
imperfecta were excluded.
Based on the six monthly follow-up questionnaires the women in
the HM were further classified as symptomatic, when mentioning pain
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or disability at any time during stair-climbing during the six months.
In this way three groups were formed: women with normal mobility
(NM), hypermobile women with symptoms (HM-s) and asymptomatic
hypermobile women (HM-as).
Questionnaires
The questionnaires used in the current study were the Canadian
Occupational Performance Measure (COPM), the International
Physical Activity Questionnaire (IPAQ) and a face validated
questionnaire. In the current project the official validated version of
the German version for both questionnaires was used. The interview
was done in one day and symptoms were recorded for the following six
months by questionnaire as described below in detail.
Canadian occupational performance measure
The Canadian Occupational Performance Measure (COPM) was
developed by occupational therapists as a tool to capture the problems
of patients in daily life in a more individual way. The procedure is that
in a semi-structured interview the patient has to identify up to five
problematic activities. Then, these activities have to be judged on a
scale from 1 to 10 for performance and satisfaction with the
performance of each activity. The measurement performance of the
COPM displays validity in a wide-variety of clinical contexts. The
COPM is also a feasible, acceptable and helpful clinical tool within the
therapeutic process [27]. The reproducibility (reliability and inter-rater
agreement) of the COPM for the prioritized problems was moderate.
The reproducibility of the mean performance and satisfaction scores
was moderate, but it was poor for the scores for the separate problems.
Therefore, only the mean scores should be used for individual
assessment [28].
The COPM has demonstrated a test-retest reliability in patients with
spinal-cord injuries with the following values r=0.80 for performance
and r=0.89 for satisfaction; ICC=0.92 for performance and ICC=0.90
for satisfaction. Therefore, this questionnaire has been shown to be a
valid measure across diagnostic categories and treatment settings [29].
The results of another study provide supportive evidence of the
convergent and divergent validity of the COPM. The data supports the
assumption that the COPM provides information that cannot be
obtained with current standardized instruments to measure health
[30]. The COPM provides a patient-centered outcome measure that
displays good external validity and responsiveness to change [28].
The international physical activity questionnaire
The International Physical Activity Questionnaire (IPAQ) is an
assessment developed in 1998 as a more precise tool to detect physical
activity in daily life. The questionnaire (long format) consists of 4
domains: during transportation, at work, during household and
gardening tasks and during leisure time, including exercise and sport
participation. According to Craig et al. [31] IPAQ instruments have
acceptable measurement properties that are at least as good as other
established self-reports. The long format is recommended for research
requiring more detailed assessments. Hagströmer et al. [32] show that
the long, self-administered IPAQ questionnaire has acceptable validity
when assessing levels and patterns of physical activity in healthy adults.
Face validated questionnaire and follow-up
A COPM was conducted with each subject on the day of
assessment. A face validated questionnaire was generated comprising
two individually defined problems and three generally known
problems in hypermobility. The general problems were defined as the
following:
• Lifting 10 kg
• Descending stairs
• Remaining in any sustained position
With the questionnaire the participants were first asked to judge the
five problems relevant to a general overview of their impairment on a
scale from zero (=no problems) to five (=not possible to fulfill the
task). Then they had to identify where, that means in which joint or
body region, they have pain during the five activities. After that they
were asked to write whether they felt anything other than pain when
performing the activities, for example, weakness or a feeling of
blockade in a joint. It was possible to give multiple answers to these
questions. They then had to determine the intensity of pain during the
activities on a scale from zero (=no pain) to ten (=maximum pain).
Finally, they had to specify how often they suffer from their disorders
on a scale from one (=never) to six (=several times a day). This
individual questionnaire was used in the follow-up acquisition over the
six month period. The questionnaire was filled in once a month.
Analyses and statistics
Quantitative evaluation: This analysis is a part of a larger cross-
sectional project aiming to compare women with and without GJH.
This study with post hoc data analyzes was designed as an exploratory
study analyzing data from the original study. For the quantitative
evaluation, descriptive statistical data of selected parameters were
presented as means and standard deviations. Normal distribution of
each variable was checked using the Kolmogorov-Smirnov test with
the Lilliefors test (p ≤ 0.05 means a normal distribution). Due to the
type of rank data the significance of differences between the three
independent groups were calculated with the nonparametric Kruskal-
Wallis-Test for COPM. The IPAQ was evaluated with ANOVA and
Tukey post-hoc tests. P-values ≤ 0.05 were considered statistically
significant. The statistical calculations were conducted using SPSS
(Version 24.0, IBM, USA).
Descriptive evaluation: The qualitative evaluation of the follow-up
questionnaire was done for the three groups, normomobile (NM),
hypermobile with symptoms (HM-s) and hypermobile participants
without symptoms (HM-as). Analysis of the individual problems, the
localization of the disorders and the type of disorders was conducted.
Results
There were no significant differences between persons in the three
groups, normomobile (NM), hypermobile with symptoms (HM-s) and
hypermobile without symptoms (HM-as) in age, weight, height and
BMI (Table 1). Twenty-five participants could not be classified further
because of missing follow up data. At the date of measurement we also
had a few drop outs because the criteria for the Beighton Score were
not fulfilled (in knee-extension right and/or bending forward not
flexible enough). Unfortunately we have no exact number at this point.
This fact might mention as limitation in the discussion.
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The last dropout we had with the questionnaires, because 25
subjects never sent back their questionnaires.
COPM: There was no significant difference in COPM data between
the three groups as shown in Table 2.
 NM(n=67)
HM-s
(n=56)
HM-as
(n=47)
ANOVA (post-hoc Tukey)
p-value
Age years 24.8 (5.4) 25.3 (5.4) 25.7 (5.3) 0.701
Height cm 165.7 (5.7) 166.9 (6.2) 167.1 (5.4) 0.378
Mass kg 60.1 (6.9) 60.2 (7.6) 61.6 (7.6) 0.529
BMI kg/m2 21.9 (2.4) 21.6 (2.5) 22.1 (2.5) 0.644
Beighton-Score n/9 0.3 (0.5) 7.8 (1.0) 7.7 (1.0)
<0.001
(HM-s vs. HM-as 0.740
HM-s vs. NM <0.001
HM-as vs. NM <0.001)
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as: Hypermobile group without symptoms
Table 1: Group characteristics for the normomobile (NM), hypermobile (HM) and symptomatic (HM-s) and asymptomatic hypermobile (HM-
as) groups presented as mean (standard deviation) values for age, height, mass, BMI and Beighton-Score.
NM
(n=65)
HM-s
(n=56)
HM-as
(n=47)
Kruskal-Wallis
p-value
COPM Performance n/10 5.5 (5.0-6.5) 5.5 (4.5-6.5) 6.0 (5.0-7.0) 0.7
COPM Satisfaction n/10 5.0 (4.0-6.5) 5.0 (4.0-6.5) 5.5 (4.0-7.0) 0.534
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as: Hypermobile group without symptoms
Table 2: COPM data for the three groups, normomobile and hypermobile participants with and without symptoms as median values (Q1-Q3).
IPAQ: There was a significant difference in minutes of activity per
day. The highest activity level was achieved in the HM-s group
(p=0.028 between NM and HM-s) (Table 3).
 NM(n=65)
HM-s
(n=56)
HM-as
(n=47)
ANOVA (post hoc
Tukey)
p-value
IPAQ Score
(Total) METS
3157
(2145)
4109
(2453)
3440
(1818) 0.072
IPAQ Score min/day 407(138)
485
(147)
437
(165)
0.028
(NM vs. HM-s 0.021)
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as:
Hypermobile group without symptoms
Table 3: IPAQ data for the three groups, normomobile and
hypermobile participants with and without symptoms as mean values
(SD).
Individual problems: In all three groups similar disorders were
mentioned in the COPM-Questionnaire as the most limiting ones,
namely ‘Remaining in any sustained position’ (Table 4).
 NM (n=67) HM-s (n=56) HM-as (n=47)
Sports 20.9% (14) 28.6% (16) 17.0% (8)
Repetition 2.9% (2) 16.1% (9) 12.8% (6)
Sustained position 37.3% (25) 30.0% (17) 29.8% (14)
Lifting 22.4% (15) 16.1% (9) 23.4% (11)
Walking 4.5% (3) 10.7% (6) 17.0% (8)
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as:
Hypermobile group without symptoms
Table 4: Individual problems mentioned in the COPM by the three
groups NM, HM-s, HM-as frequency (%(n)).
Localization of disorders: Persons in all the three groups indicated
different localizations, but in all three groups back and neck problems
were among the three most important localizations (Table 5).
NM (n=67) HM-s (n=56) HM-as (n=47)
Foot left 4.5% (3) 7.1% (4) 8.5% (4)
Foot right 4.5% (3) 10.7% (6) 6.4% (3)
Knee left 9.0% (6) 16.1% (9) 8.5% (4)
Knee right 13.4% (9) 17.9% (10) 8.5% (4)
Hip left 3.0% (2) 7.1% (4) 2.1% (1)
Hip right 4.5% (3) 7.1% (4) 2.1% (1)
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Back 35.8% (24) 37.5% (21) 25.5% (12)
Neck 17.9% (12) 26.8% (15) 21.3% (10)
Others (arms, shoulders) 11.9% (8) 23.2% (13) 17.0% (8)
No disorders 26.9% (18) 14.3% (8) 34.0% (16)
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as:
Hypermobile group without symptoms.
Table 5: Localization of the disorders mentioned in the face validated
questionnaire by the three groups NM, HM-s, HM-as (%(n)), sum over
6 monthly questionnaires).
 NM (n=67) HM-s (n=56) HM-as (n=47)
Pain 46.3% (31) 73.2% (41) 46.8% (22)
Unstableness 5.9% (4) 10.7% (6) 6.4% (3)
Blockade 8.9% (6) 12.5% (7) 8.5% (4)
Others 1.5% (1) 7.1% (4) 21.3% (10)
NM: Normomobile group; HM-s: Hypermobile group with symptoms; HM-as: Hypermobile group without symptoms.
Table 6: Type of disorders mentioned in the face validated questionnaire by the three groups NM, HM-s, HM-as (% (n) sum over 6 monthly
questionnaires).
Type of disorders: Participants in all three groups specified different
types of disorders, but the most frequent type of disorder mentioned in
the 3 different groups in the context of the individual problem was
pain (Table 6).
Discussion
The present study looked at potential differences between persons
with generalized hypermobility and those with normal mobility with
regard to symptoms and activity level. The highest activity level was
recorded for the hypermobile group with symptoms. But only one
outcome from several evaluations, namely, minutes of activity per day
was significantly higher between HM-s and NM showing that the HM-
s group was active longer, but the degree and type of activity needs
further evaluation. To our knowledge, there are three studies on this
subject. The first study was done with school children and there no
correlation was found between hypermobility, activity level and motor
competence [33]. The second study was done with adults suffering
from Ehlers-Danlos syndrome type III (hypermobility type). In this
study the hypermobile patients showed a lower activity level in sports
than controls [16]. Finally Schmidt et al. [23] investigated how people
with JHS make decisions about physical activity. The results of their
study indicate that several activities were avoided, because people were
too afraid, and others were performed because convenience took
priority over the disorders. The authors summarized that the activity
has to be discussed in detail during the rehabilitation process with
people experiencing joint hypermobility. In the context of the activity
level of hypermobile persons it seems to be important that the activity
level itself is monitored in a proper way and that it is then linked to the
symptoms. Furthermore, the reasons why hypermobile persons are
active or not have to be explored and such aspects have to be taken
into consideration for further research.
In our study the evaluation of the symptoms was done with two
different tools. The COPM was an important aid in detecting the
individual disorders of each participant in a first step. However, the
evaluation of performance and satisfaction revealed no significant
differences between participants with HM and NM. The COPM does
not seem to be sensitive enough to discriminate between these groups.
The values for performance and satisfaction were generally higher
compared to a study done with patients with chronic low back pain
[27]. Based on the data of 195 participants it was possible to build
three subgroups based on a follow-up questionnaire. With reference to
the individual problems mentioned in the COPM the women in all
three groups had some problems in ‘Remaining in any sustained
position’, ‘Sports’ and ‘Lifting’. Additionally women in the HM-s group
mentioned problems with ‘Lifting’ and ‘Repetition’. Regarding the
localization in all three groups, ‘Back’, ‘Neck’ or ‘No disorders’ were
given as most often responses. In the NM and HM-s group ‘Back’ was
the most affected region. In the HM-as group ‘No disorders’ was
mentioned most frequently. However, in the HM-s group generally
more disorders were mentioned by more persons. On the other hand,
less problems during specific activities were mentioned, maybe also
because these activities were less often performed, i.e. for walking.
For the type of disorders in all three groups ‘pain’ was the most
important one. In the NM and HM-s groups ‘Blockade’ and
‘Unstableness’ were second and third. In the HM-as group ‘Others/
Weakness’ and ‘Blockade’ were second and third. Also, in two other
studies, the authors have build clusters within the clinical
heterogeneity of hypermobility. In these studies the criteria to build the
subgroups were based on further anamnestic information, e.g.
psychosocial health and non-musculoskeletal symptoms [2,11]. Thus,
the advantage in our study is that the grouping was based on
observations during six months. In another investigation it was
observed that hypermobile persons have problems in different joints of
the upper and lower extremities, but also have back and neck pain [2].
Hip problems were observed in a study done with dancers, but it is not
only the hypermobility itself that is a problem for these subjects, but
also the altered lumbo-pelvic pattern of movement [36]. One large
study showed that hypermobile persons have widespread pain at
different localizations and a different body perception and
proprioception than healthy controls [4].
In the current study the result of the question about the localization
of the disorders is as expected and as described in the literature
[34,35]. Although the collected data on localization and type of
disorders is the sum of all the problems ever mentioned over a period
of 6 months, direct comparison between the three groups NM, HM-as
and HM-s remains difficult. The results of the current study and the
descriptions reported in the literature may indicate that the treatment
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of hypermobile persons should not be too localized or guided by a
biomechanical approach only. There are some current studies, which
took this into consideration such as Palmer et al. [37]. They concluded
in their study that the physiotherapeutic management of persons
experiencing a hypermobility syndrome should be focused on advice,
education, exercise and self-management, but more specific research is
still required [21,37]. In another study there is some evidence that
people with joint hypermobility syndrome improve with exercise but
there is no convincing evidence for specific types of exercise or that
exercise is better than control [38].
As a limitation of this study the follow-up, and thus the
subgrouping, with the face-validated questionnaire was affected by 25
dropouts, because participants did not return the questionnaire despite
requests by mail twice. This value translates to 12% of all participants.
Retrospectively, there were some unclear instructions on how to fill in
the questionnaire, especially with regard to linked questions. Once a
question was answered with ‘No disorders’ the following questions did
not ask for specifications. This fact led to missing data and maybe to
some misrepresentation of the symptoms. In summary, on the one
hand, the classification of the three groups based on this questionnaire
is disputable. But, on the other hand, the observation of all participants
over a period of 6 months is strength and might be mandatory to
evaluate the clinical pattern of hypermobility. However, since the
planning of the present study, the Bristol Impact Questionnaire on
Hypermobility (BIoH) as the first condition-specific tool for JHS has
been developed and published [39]. It correlates strongly with the
Physical Component Score of the SF-36. Other psychometric
properties of the questionnaire such as test-retest reliability and
sensitivity to change are yet to be established [39]. However, in a future
project the BloH might be used, but the questionnaire would have to
be translated first, since a German version does not yet exist.
An important strength of this study is that 195 women were
evaluated, which is a rather large sample in the field of hypermobility.
Furthermore, the symptoms were not only recorded once but regularly
over a period of six months. This might be important because BJGH
and JHS often show undulating patterns with painful periods followed
by states of relatively pain-free activities. Screening of participants was
done by the Beighton Score, which achieved good inter-tester
reliability and good to very good intra-tester reliability. However, there
is a lack of evidence concerning the validity of the screening tools
[9,40]. This score measures only the range of motion in several joints.
For further research it would be important to use the new published
criteria to have a more specific tool to detect JHS [11].
In the present study, the three groups NM, HM-s, HM-as were
compared for individual problems, localization and type of disorders.
In this comparison the group HM-as reported some problems despite
being generally asymptomatic. This fact led us to assume that
hypermobile persons do indeed have problems in daily life before they
are diagnosed with JHS This context should be taken into
consideration when planning appropriate management and treatment
and to avoid serious consequences, e.g. episodes of chronic pain. For
further research it may also be helpful to compare the hypermobile
group with persons who are suffering from nonspecific low back pain
(nLBP), because their situation is actually similar: Moseley, in his
study, obtained some results indicating that body perception in chronic
low back pain is disturbed and tactile acuity is decreased [37,41]. For
nLBP one of the most promising possibilities for treatment is exercise
[41]. In the current literature motor control exercise and graded
activity are recommended as treatments [43-45]. Macedo et al. [44]
employed a simple questionnaire in their study on clinical instability,
which may help to identify those patients with nLBP who respond best
to either motor control or graded activity exercises. In another study by
Saner et al. [46] a tailored exercise program versus general exercise for
a subgroup of patients with low back pain and movement control
impairment was investigated. This study found no additional benefit of
specific exercises targeting motor control impairment. In summary,
both groups (nLBP and BGJH) have reduced neuromuscular abilities
and have a disturbed body perception. The question of whether both
clinical patterns have to be managed the same way or which type of
therapy would be the most effective one has to be investigated in future
research projects.
Conclusion
This study showed slight differences in symptoms and activity levels
between hypermobile women and women with normal mobility.
Although the hypermobile women in this project were classified as
BGJH, half of them complained of pain and disability. Therefore, a
more comprehensive procedure of screening and a more specific
investigation, mainly in the form of a more focused questionnaire,
might help to evaluate the smooth transition between women with
hypermobility and those with JHS, or according to the new
classification hEDS. Finding more objective and discriminating
parameters might help to subgroup this complex clinical picture and
facilitate a more individual treatment regimen.
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